Other Cancer
18
4
7
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
0.0%
0 terminated out of 18 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
67%
6 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (18)
Evaluation of Novel Cone-Beam CT for Guidance and Adaptation of Precision Radiotherapy
Development of an Intervention to Enhance Cancer Pain Management
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
A Randomised Controlled Trial to Evaluate the Impact of Complement Theory's Live CoActive Exercise Coaching and Personalized Digital Application on Cancer Survivors' Quality of Life
Ruxolitinib for Bronchiolitis Obliterans Syndrome (BOS) After Allogeneic Hematopoietic Cell Transplantation (HCT)
Advance Care Planning: Promoting Effective and Aligned Communication in the Elderly
Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
Symptom Management Implementation of Patient Reported Outcomes in Oncology
Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients
Multimodal Mobile Intervention Application (App) to Address Sexual Dysfunction in Hematopoietic Stem Cell Transplant Survivors
Locally AblatiVe TherApy in OLigO-pRogressive SOlid TUmorS (VALOROUS)
Pilot Feasibility of the Pediatric Cancer Resource Equity (PediCARE) Intervention
Shared Care: Patient-Centered Management After Hematopoietic Cell Transplantation
The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy
Testing Feasibility of Motivational Interviewing for Patient-Reported Cancer Pain Goals
A Geriatric Oncology Collaborative Care Intervention for Older Adults With Advanced Cancer
SHARE (Sharing Goals and Preferences) Study
Circulating Tumor DNA Exposure in Peripheral Blood